News & Insights

Gunderson Dettmer partner, Tim Ehrlich, to moderate a panel at the annual Genesis London Conference

Gunderson Dettmer Strategic Transactions and Licensing partner Brendan McCarthy hosted the webinar “’What’s Market’ in University Licenses in the Life Sciences Industry” to discuss the key economic terms in university license agreements.

Medical technology company, ABM Respiratory Care (ABMRC), announces its $14.8 million Series B financing led by Peter Soderberg, ABMRC’s Chairman of the Board and Managing Partner of Worthy Venture Resources, with participation from Bluwave Capital

Leading health and wellness platform, Hims & Hers, announces its definitive agreement to acquire Europe-based digital health platform, ZAVA

Cambridge-based biopharmaceutical company pioneering RNAi-based medicine, City Therapeutics, announces its $ 1 billion strategic collaboration with Biogen Inc., a company focused on pioneering innovative science to deliver new medicines

PitchBook names Gunderson Dettmer as the most active law firm globally by the Q1 2025 Global League Tables, securing the top spot for venture capital law firms

Gunderson Dettmer announces the addition of Life Sciences Partner, Adrian Rich, based in the Northern California offices

Managing over 280 financings and more than $14 billion in invested capital for the most promising startups worldwide, Gunderson Dettmer was recognized as the most active law firm globally by the PitchBook Global League Tables for the third quarter in a row